SALT LAKE CITY, Nov. 18, 2014 /PRNewswire/ -- Great Basin Scientific, Inc. (NASDAQ: GBSN), a molecular diagnostics company, today announced that the management will host a conference call and webcast to provide an update on Great Basin's progress and development programs on Thursday, Nov. 20, at 4:30 pm EST time.
"We are pleased with the progress we have made since the Company's recent IPO and would like to provide our investors with an update directly from Great Basin's management," said Ryan Ashton, President and Chief Executive Officer of Great Basin Scientific. "We will continue to strive to bring value to both our customers and shareholders and are looking forward to addressing our investors' questions. We believe our molecular diagnostic system will allow hospital laboratories to implement cost effective, sample-to-result, molecular testing for better patient outcomes."
Call and Webcast Details:
The live call may be accessed by dialing 1-877-407-0789 for domestic callers or 1-201-689-8562 for international callers. A live webcast of the conference call will be available online from the investor section of Great Basin's website at http://www.gbscience.com and will be available for replay following the call for 60 days.
About Great Basin Scientific
Great Basin Scientific is a molecular diagnostics company that commercializes breakthrough chip-based technologies. The Company is dedicated to the development of simple, yet powerful, sample-to-result technology and products that provide fast, multiple-pathogen diagnoses of infectious diseases. The Company's vision is to make molecular diagnostic testing so simple and cost-effective that every patient will be tested for every serious infection, reducing misdiagnoses and significantly limiting the spread of infectious disease. More information can be found on the company's website at www.gbscience.com.
This press release includes forward-looking statement regarding events, trends and business prospects, which may affect our future operating results and financial position. Forward-looking statements involve risk and uncertainties, which could cause actual results to differ materially, and reported results should not be considered as an indication of future performance. These risk and uncertainties include, but are not limited to: (i) our limited operating history and history or losses; (ii) our ability to develop and commercialize new products and the timing of commercialization; (iii) our ability to obtain capital when needed; and (iv) other risks set forth in the Company's filings with the Securities and Exchange Commission, including the risks set forth in the company's Quarterly Report on Form 10-Q for the quarter ended September 30, 2014. These forward-looking statements speak only as of the date hereof and Great Basin Scientific specifically disclaims any obligation to update these forward-looking statements, except as required by law.
Martina Schwarzkopf, Ph.D.
Russo Partners, LLC
Investor Relations Contact:
SOURCE Great Basin Scientific, Inc.